SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $542,000 | +24.3% | 4,901 | -12.7% | 0.05% | +19.0% |
| Q2 2021 | $436,000 | -44.7% | 5,612 | -47.0% | 0.04% | -25.0% |
| Q1 2021 | $789,000 | +34.4% | 10,586 | +207.4% | 0.06% | -11.1% |
| Q4 2020 | $587,000 | +34.3% | 3,444 | +26.4% | 0.06% | +26.0% |
| Q2 2020 | $437,000 | -9.0% | 2,725 | -32.3% | 0.05% | +85.2% |
| Q1 2019 | $480,000 | -60.9% | 4,027 | -64.2% | 0.03% | -59.1% |
| Q4 2018 | $1,227,000 | +57.9% | 11,240 | +91.1% | 0.07% | +94.1% |
| Q2 2018 | $777,000 | +18.4% | 5,881 | -33.6% | 0.03% | -2.9% |
| Q1 2018 | $656,000 | – | 8,857 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |